« Back

Travere Therapeutics to Present at Upcoming Investor Conferences

Mar 28, 2023

SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming conferences:

Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days
Tuesday, April 4, 2023, at 3:55 p.m. ET

BofA Securities 2023 Health Care Conference
Wednesday, May 10, 2023, at 3:40 p.m. PT

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit

Nivi Nehra
Vice President, Corporate Communications
Naomi Eichenbaum
Vice President, Investor Relations

Primary Logo

Source: Travere Therapeutics, Inc.